Women with systemic rheumatic diseases (SRDs) commonly report experiencing disease flares and worsening SRD symptoms ...

The ACR has released a summary of a new 2024 guideline for the screening, treatment, and management of Lupus Nephritis.

Lupus Therapeutics introduces the IDEAL Initiative to fund clinical studies exploring the impact of diet and the microbiome ...

Objective Previous studies have revealed functional changes within the cerebral hemispheres of patients with SLE; however the ...

Systemic Lupus Erythematosus (SLE), commonly known as lupus ... remains unclear but is believed to be a combination of genetic predisposition and environmental triggers that disrupt the immune system.

Systemic lupus erythematosus (SLE) is an autoimmune disease marked by premature atherosclerosis ... is a long-term illness that can result in a wide variety of debilitating symptoms including ...

Dapirolizumab pegol was better than a placebo at controlling disease activity in systemic lupus erythematosus patients in a Phase 3 trial.

Objective Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by a loss of immune tolerance, affecting ...

Columnist Marisa Zeppieri welcomes the season of holiday food while offering tips to get people with lupus through any ...

DelveInsight's 'Systemic Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of pipeline ...

The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...

Cabaletta Bio (CABA) announced new and updated clinical data on CABA-201 demonstrating the potential to achieve drug-free, compelling clinical ...